Monday, January 30, 2023 | Back issues
Courthouse News Service Courthouse News Service

Pfizer Demands JAMA’s Notes On Celebrex

CHICAGO (CN) - Pfizer asked the Federal Court to order nonparties The American Medical Association and the Journal of The American Medical Association to turn over "peer review comments, draft manuscripts, and correspondence with the authors" of articles about Celebrex and Bextra. The JAMA is willing to turn over only the published articles. See filing in Bextra and Celebrex Marketing Sales Practices and Product Liability Litigation.

Read the Top 8

Sign up for the Top 8, a roundup of the day's top stories delivered directly to your inbox Monday through Friday.